Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV)

A Double-blind, Multi-center, Randomized, Placebo Controlled, Dose-ranging Study to Determine the Efficacy and Safety of SPL7013 Gel (VivaGel®) Administered Vaginally in the Treatment of Bacterial Vaginosis

The purpose of this study is to determine the efficacy of SPL7013 Gel in the treatment of bacterial vaginosis.

Inclusion Criteria:

• Women aged 18-45 years with a diagnosis of BV according to Amsel's criteria and a Nugent score of ≥4
• Otherwise healthy

Exclusion Criteria:

• No active STIs